Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT), clinical chemistry, chemiluminescent assays, hematology, coagulation, urinalysis and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. We also manufacture analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics.
Getein tPSA Fast Test Kit is used as an aid in the diagnosis and management of patients with prostate cancer.
Getein CEA Fast Test Kit is used as a tumor marker to monitor colorectal carcinoma treatment and follow-up.
Getein AFP Fast Test Kit is used as an aid in the diagnosis and management of patients with liver cancer or cancer of the ovaries or testicles, and also help to monitor the health of people with cirrhosis or hepatitis.
Getein fPSA Fast Test Kit is used for dynamic monitoring of patients with malignant tumors to assist in judging the disease process or treatment effect.
Subscribe to our weekly newsletter and receive exclusive offers on products you love!
X
